New research shows depression and anxiety relate to early RA disease activity.
According to new research, obesity -- both in childhood and adulthood -- increases the risk of hip and knee osteoarthritis.
Researchers found that sleep problems predict chronic, widespread pain.
Rheumatoid arthritis patients are 44 percent likelier than the general public to suffer from coronary disease, and their syblings are 23 percent more likely to suffer from the same.
The strongest predictors of patients not achieving early remission with a year, according to new research , were obesity in women and smoking in men.
The European League Against Rheumatism launched its “Don’t Delay, Connect Today” campaign, EULAR announced on June 14 at its annual event in Amsterdam that the campaign has reached more than 20 countries in Europe.
Women with rheumatoid arthritis who are pregnant tend to deliver prematurely and their babies often have low weight. That’s according to new research presented June 14 in Amsterdam at the Annual European Congress of Rheumatology. The study of 845 pregnant...
People living with RA and AS were twice as likely to attempt self-harm, according to new research presented June 14 in Amsterdam at the Annual European Congress of Rheumatology.
Two studies presented on June 14 in Amsterdam at the Annual European Congress of Rheumatology spell promising results for lupus patients.
A cohort study presented at the Annual European Congress of Rheumatology on June 14 in Amsterdam found that patients who take tumour necrosis factor (TNF) inhibitors experience the least disease progression when they add nonsteroidal anti-inflammatory drugs (NSAIDs).
Lower levels of physical performance and more severe disease are associated with higher levels of depression in knee osteoarthritis patients.
New research found no difference in rates of cancer between rheumatoid arthritis patients who switched to the biologic tocilizumab and those who began taking a tumor necrosis factor (TNF) inhibitor.
Early, intensive treatment of rheumatoid arthritis can, in the long-term, bring mortality rates for RA patients in line with those rates in the general population.
Researchers have found that joint replacements decreased by more than half in RA patients between 1997 and 2010.
A new study indicates that two infusions of zoledronic acid -- one per year -- didn’t greatly reduce pain or bone marrow damage in knee osteoarthritis patients.
Two studies presented on June 13 in Amsterdam at the 2018 Annual European Congress of Rheumatology better understand -- and perhaps even identify -- which at-risk patients will develop rheumatoid arthritis.
New research reveals elevated heart risks associated with osteoarthritis are linked to non-steroidal anti-inflammatory drugs (NSAIDs), the most common drugs used to fight inflammation.
CreakyJoints Data Demonstrates Barriers to Treatment in Rheumatoid Arthritis. Poster to be Presented at the Annual European Congress of Rheumatology (EULAR 2018)